David García-Bernal

24PUBLICATIONS
39CO-AUTHORS
Infectious diseasesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical virologySolution chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 12, 2026
Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

|Mar 11, 2026
Minocycline and bone marrow-derived mononuclear cells as potential therapeutics for hereditary retinal degenerations.

Alba Videla-Ristol, Ana Martínez-Vacas, David García-Bernal

|Jul 27, 2024
Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects.

Jesús I Gil-Chinchilla, Agustín G Zapata, Jose M Moraleda

|Apr 27, 2024
Comparative Cytotoxicity of Menthol and Eucalyptol: An In Vitro Study on Human Gingival Fibroblasts.

Clara Puig-Herreros, José Luis Sanz, David García-Bernal

|Nov 11, 2022
Are Endodontic Solvents Cytotoxic? An In Vitro Study on Human Periodontal Ligament Stem Cells.

José Luis Sanz, Sergio López-García, Leopoldo Forner

|Oct 19, 2022
Enforced mesenchymal stem cell tissue colonization counteracts immunopathology.

David García-Bernal, Miguel Blanquer, Carlos M Martínez

Pageof 4

Frequent Collaborators

10 joint publications

Francisco Javier Rodríguez-Lozano

5 joint publications

Jose M Moraleda

4 joint publications

Leopoldo Forner

3 joint publications

Carlos M Martínez